769 |
Treatment Regimen for DSTB – Adult |
26/03/2022 |
|
771 |
Types of Drug Resistance Tuberculosis -DRTB |
26/03/2022 |
|
780 |
Monitoring adherence to TPT |
26/03/2022 |
|
775 |
Target groups for TPT |
26/03/2022 |
|
787 |
Silicosis in TB Patients |
26/03/2022 |
|
620 |
Treatment Support and Monitoring of TB Patient |
26/03/2022 |
|
795 |
Role of TS |
26/03/2022 |
|
796 |
Registering a TS in Nikshay |
26/03/2022 |
|
797 |
Treatment Support Groups |
26/03/2022 |
|
798 |
Recording Adherence in Treatment card |
26/03/2022 |
|
799 |
Recoring Adherence using TB Arogya Sathi Application |
26/03/2022 |
|
819 |
Support for Rehabitilation |
26/03/2022 |
|
841 |
Maintenance of records - NTEP Drug Stock Register |
27/03/2022 |
|
842 |
Managerial Skills |
27/03/2022 |
|
846 |
Reconstitution of drugs like second line, newer, TPT etc |
27/03/2022 |
|
850 |
Stock register for Drugs |
27/03/2022 |
|
858 |
Stakeholders for Private Sector Engagament |
27/03/2022 |
|
866 |
PHA for patient notified from the private sector |
27/03/2022 |
|
869 |
Incentive For Notification and Outcome Declaration |
27/03/2022 |
|
815 |
Monitoring of Adherence by Pateint/TS |
27/03/2022 |
|
814 |
Monitoring of Adherence by NTEP Staff |
27/03/2022 |
|
824 |
Stakeholders/Systems for DBT under NTEP |
27/03/2022 |
|
831 |
Transport Support for TB Patients in Notified Tribal Areas |
27/03/2022 |
|
833 |
Roles and responsibilities of Beneficiaries and NTEP Staff to process DBT |
27/03/2022 |
|
836 |
Registration of Private Providers and Processing Benefits |
27/03/2022 |
|
571 |
Importance of Community Engagement in TB |
27/03/2022 |
|
955 |
Patient-provider meetings |
27/03/2022 |
|
940 |
What is A in ACSM |
27/03/2022 |
|
941 |
What is C in ACSM |
27/03/2022 |
|
942 |
What is SM in ACSM |
27/03/2022 |
|